Could CAR-T-cell therapy offer hope to children with cancer?
Elie Dolgin • December 19, 2022
The immunotherapy is beginning to show promise in solid tumours, but researchers want more dedicated research in young people.
Continue reading at Nature Outlook.
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.